536 related articles for article (PubMed ID: 16392116)
1. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Dutta R; McDonough J; Yin X; Peterson J; Chang A; Torres T; Gudz T; Macklin WB; Lewis DA; Fox RJ; Rudick R; Mirnics K; Trapp BD
Ann Neurol; 2006 Mar; 59(3):478-89. PubMed ID: 16392116
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial changes within axons in multiple sclerosis.
Mahad DJ; Ziabreva I; Campbell G; Lax N; White K; Hanson PS; Lassmann H; Turnbull DM
Brain; 2009 May; 132(Pt 5):1161-74. PubMed ID: 19293237
[TBL] [Abstract][Full Text] [Related]
3. Targeting mitochondria to protect axons in progressive MS.
Campbell G; Licht-Mayer S; Mahad D
Neurosci Lett; 2019 Sep; 710():134258. PubMed ID: 31082453
[TBL] [Abstract][Full Text] [Related]
4. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis.
Trapp BD; Stys PK
Lancet Neurol; 2009 Mar; 8(3):280-91. PubMed ID: 19233038
[TBL] [Abstract][Full Text] [Related]
5. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
Dutta R; Chang A; Doud MK; Kidd GJ; Ribaudo MV; Young EA; Fox RJ; Staugaitis SM; Trapp BD
Ann Neurol; 2011 Mar; 69(3):445-54. PubMed ID: 21446020
[TBL] [Abstract][Full Text] [Related]
6. Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis.
Sathornsumetee S; McGavern DB; Ure DR; Rodriguez M
Am J Pathol; 2000 Oct; 157(4):1365-76. PubMed ID: 11021839
[TBL] [Abstract][Full Text] [Related]
7. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.
Zambonin JL; Zhao C; Ohno N; Campbell GR; Engeham S; Ziabreva I; Schwarz N; Lee SE; Frischer JM; Turnbull DM; Trapp BD; Lassmann H; Franklin RJ; Mahad DJ
Brain; 2011 Jul; 134(Pt 7):1901-13. PubMed ID: 21705418
[TBL] [Abstract][Full Text] [Related]
8. Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.
Licht-Mayer S; Campbell GR; Canizares M; Mehta AR; Gane AB; McGill K; Ghosh A; Fullerton A; Menezes N; Dean J; Dunham J; Al-Azki S; Pryce G; Zandee S; Zhao C; Kipp M; Smith KJ; Baker D; Altmann D; Anderton SM; Kap YS; Laman JD; Hart BA'; Rodriguez M; Watzlawick R; Schwab JM; Carter R; Morton N; Zagnoni M; Franklin RJM; Mitchell R; Fleetwood-Walker S; Lyons DA; Chandran S; Lassmann H; Trapp BD; Mahad DJ
Acta Neuropathol; 2020 Aug; 140(2):143-167. PubMed ID: 32572598
[TBL] [Abstract][Full Text] [Related]
9. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
Bjartmar C; Wujek JR; Trapp BD
J Neurol Sci; 2003 Feb; 206(2):165-71. PubMed ID: 12559505
[TBL] [Abstract][Full Text] [Related]
10. Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex.
Preziosa P; Kiljan S; Steenwijk MD; Meani A; van de Berg WDJ; Schenk GJ; Rocca MA; Filippi M; Geurts JJG; Jonkman LE
Brain; 2019 Jul; 142(7):1921-1937. PubMed ID: 31168614
[TBL] [Abstract][Full Text] [Related]
11. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
[TBL] [Abstract][Full Text] [Related]
12. Axonal changes in chronic demyelinated cervical spinal cord plaques.
Lovas G; Szilágyi N; Majtényi K; Palkovits M; Komoly S
Brain; 2000 Feb; 123 ( Pt 2)():308-17. PubMed ID: 10648438
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.
Dutta R; Trapp BD
Prog Neurobiol; 2011 Jan; 93(1):1-12. PubMed ID: 20946934
[TBL] [Abstract][Full Text] [Related]
14. Review: Mitochondria and disease progression in multiple sclerosis.
Mahad D; Lassmann H; Turnbull D
Neuropathol Appl Neurobiol; 2008 Dec; 34(6):577-89. PubMed ID: 19076696
[TBL] [Abstract][Full Text] [Related]
15. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger.
Craner MJ; Newcombe J; Black JA; Hartle C; Cuzner ML; Waxman SG
Proc Natl Acad Sci U S A; 2004 May; 101(21):8168-73. PubMed ID: 15148385
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis.
Campbell G; Mahad DJ
FEBS Lett; 2018 Apr; 592(7):1113-1121. PubMed ID: 29453889
[TBL] [Abstract][Full Text] [Related]
18. [Neuronal injury in multiple sclerosis].
Correale J; Meli F; Ysrraelit C
Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
[TBL] [Abstract][Full Text] [Related]
19. Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.
Young EA; Fowler CD; Kidd GJ; Chang A; Rudick R; Fisher E; Trapp BD
Ann Neurol; 2008 Apr; 63(4):428-35. PubMed ID: 18438950
[TBL] [Abstract][Full Text] [Related]
20. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
